Literature DB >> 15388261

Analysis of HLA-A24-restricted CMVpp65 peptide-specific CTL with HLA-A*2402-CMVpp65 tetramer.

Yasuto Akiyama1, Kiyotaka Kuzushima, Tatsuya Tsurumi, Ken Yamaguchi.   

Abstract

Developing precise and efficient methods of monitoring immune responses against cytomegalovirus (CMV) infection in immunocompromised transplantation patients is important. With the aim of optimizing the monitoring strategy, an HLA-A24-CMVpp65 tetramer-based analysis of CMVpp65 peptide-specific CTL lines was performed. Previously, the HLA-A24-restricted CTL epitope of CMVpp65 matrix protein was identified (QYDPVAALF aa 341-349). In the present study, CMVpp65 (aa 341-349) peptide-specific CTL lines were obtained from PBLs of 12 HLA-A24+ healthy donors by two stimulations with peptide-pulsed dendritic cells (DC). Among 12 CTL lines, 9 showed HLA-A*2402-CMVpp65 tetramer staining, which was found to be strongly co-related to the amount of IFN-gamma produced by CMVpp65 peptide-restimulated CTL lines (r=0.943, P<0.001). These results suggested that HLA-A*2402-CMVpp65 tetramer staining was an efficient way to monitor immune responses against CMV infection in HLA-A24+ immunocompromised hosts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388261     DOI: 10.1016/j.imlet.2004.07.010

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  4 in total

1.  Changes in the expression of CD106, osteogenic genes, and transcription factors involved in the osteogenic differentiation of human bone marrow mesenchymal stem cells.

Authors:  Feng Liu; Yasuto Akiyama; Sachiko Tai; Kouji Maruyama; Yoshihiro Kawaguchi; Kouji Muramatsu; Ken Yamaguchi
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

2.  Human TSLP directly enhances expansion of CD8+ T cells.

Authors:  T Akamatsu; N Watanabe; M Kido; K Saga; J Tanaka; K Kuzushima; A Nishio; T Chiba
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

3.  Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.

Authors:  Sylvia Borchers; Melanie Bremm; Thomas Lehrnbecher; Elke Dammann; Brigitte Pabst; Benno Wölk; Ruth Esser; Meral Yildiz; Matthias Eder; Michael Stadler; Peter Bader; Hans Martin; Andrea Jarisch; Gisbert Schneider; Thomas Klingebiel; Arnold Ganser; Eva M Weissinger; Ulrike Koehl
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

Review 4.  Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Justyna Ogonek; Mateja Kralj Juric; Sakhila Ghimire; Pavankumar Reddy Varanasi; Ernst Holler; Hildegard Greinix; Eva Weissinger
Journal:  Front Immunol       Date:  2016-11-17       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.